NCT05109936 Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed Administration Status RECRUITING Phase PHASE3
NCT05065606 Descriptive Analysis of Dual-energy Computed Tomography Exams of Adult Patients With Gout Status UNKNOWN Phase N/A
NCT05007392 A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout Status COMPLETED Phase PHASE3
NCT05006001 Evaluation of Colchicine and Nonsteroidal Anti-inflammatory Drug Combination Therapy and Renal Function in Gout Patients Status UNKNOWN Phase N/A
NCT04987294 Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease Status TERMINATED Phase PHASE2
NCT04987242 An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201) Status COMPLETED Phase PHASE2
NCT04966325 Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects Status COMPLETED Phase EARLY_PHASE1
NCT04960527 Acute Effects of Tart Cherry on Uric Acid and Biomarkers of CVD Risk in Healthy Individuals Status COMPLETED Phase NA
NCT04956432 A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With Gout Status COMPLETED Phase PHASE3
NCT04953533 Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of Gout Status UNKNOWN Phase N/A
NCT04952896 Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease Status COMPLETED Phase N/A
NCT04897113 Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old Status UNKNOWN Phase NA
NCT04886050 Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy Adults Status COMPLETED Phase PHASE1
NCT04875702 Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout Status RECRUITING Phase PHASE4
NCT04853160 Drug Use Study of Febuxostat After Recent Changes in the Prescribing Information Status COMPLETED Phase N/A
NCT04844814 Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation Status SUSPENDED Phase PHASE2
NCT04829435 Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase) Status COMPLETED Phase PHASE1